
Liberyx Therapeutics Announces the Appointment of Dr. Eddy Zhu as Chief CMC Officer
HONG KONG SAR, HONG KONG, March 7, 2025 /EINPresswire.com/ -- Liberyx Therapeutics, a clinical-stage biopharmaceutical company developing safe, effective, and patient-friendly drugs to treat rare, pediatric neurometabolic diseases, announces the …